Precigen, Inc. (PGEN)
6.385
-0.81
(-11.26%)
USD |
NASDAQ |
Oct 16, 16:00
6.38
0.00 (0.00%)
After-Hours: 20:00
Precigen Free Cash Flow : -115.22M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -115.22M |
| March 31, 2026 | -116.96M |
| December 31, 2025 | -89.83M |
| September 30, 2025 | -75.62M |
| June 30, 2025 | -69.78M |
| March 31, 2025 | -75.26M |
| December 31, 2024 | -76.76M |
| September 30, 2024 | -84.30M |
| June 30, 2024 | -77.93M |
| March 31, 2024 | -68.36M |
| December 31, 2023 | -68.47M |
| September 30, 2023 | -67.10M |
| June 30, 2023 | -75.25M |
| March 31, 2023 | -68.15M |
| December 31, 2022 | -69.97M |
| September 30, 2022 | -71.88M |
| June 30, 2022 | -65.78M |
| March 31, 2022 | -65.98M |
| December 31, 2021 | -63.02M |
| September 30, 2021 | -63.59M |
| June 30, 2021 | -64.33M |
| March 31, 2021 | -71.05M |
| December 31, 2020 | -84.55M |
| September 30, 2020 | -103.44M |
| June 30, 2020 | -118.33M |
| Date | Value |
|---|---|
| March 31, 2020 | -149.95M |
| December 31, 2019 | -173.81M |
| September 30, 2019 | -185.58M |
| June 30, 2019 | -188.24M |
| March 31, 2019 | -179.92M |
| December 31, 2018 | -165.83M |
| September 30, 2018 | -165.10M |
| June 30, 2018 | -163.94M |
| March 31, 2018 | -160.44M |
| December 31, 2017 | -150.80M |
| September 30, 2017 | -138.56M |
| June 30, 2017 | -128.28M |
| March 31, 2017 | -103.78M |
| December 31, 2016 | -87.86M |
| September 30, 2016 | -42.81M |
| June 30, 2016 | 33.13M |
| March 31, 2016 | 23.56M |
| December 31, 2015 | 22.92M |
| September 30, 2015 | 3.265M |
| June 30, 2015 | -54.60M |
| March 31, 2015 | -48.48M |
| December 31, 2014 | -26.23M |
| September 30, 2014 | -26.49M |
| June 30, 2014 | -34.74M |
| March 31, 2014 | -34.25M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Anika Therapeutics, Inc. | 0.562M |
| Aldeyra Therapeutics, Inc. | -22.04M |
| Repligen Corp. | 110.15M |
| AC Immune SA | -- |
| Amgen, Inc. | 10.18B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -17.81M |
| Cash from Investing (Quarterly) | 26.69M |
| Cash from Financing (Quarterly) | -0.033M |
| Free Cash Flow Per Share (Quarterly) | -0.044 |
| Free Cash Flow to Equity (Quarterly) | -18.30M |
| Free Cash Flow to Firm (Quarterly) | -15.25M |
| Free Cash Flow Yield | -5.05% |